LENZ Therapeutics Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
34.00
|
|
Average Rating
|
4.57
|
|
# Strong Buys
|
4
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
0.00
|
-0.38
|
0.00
|
0.00%
|
|
2024-06-30
|
-0.49
|
-0.40
|
0.09
|
18.37%
|
|
2024-03-31
|
-0.84
|
-3.53
|
-2.69
|
-320.24%
|
|
2023-12-31
|
-0.13
|
-0.40
|
-0.27
|
-207.69%
|
|
2023-09-30
|
-1.76
|
-2.73
|
-0.97
|
-55.11%
|
|
2023-06-30
|
-2.15
|
-6.79
|
-4.64
|
-215.81%
|
|
2023-03-31
|
-2.32
|
-3.01
|
-0.69
|
-29.74%
|
|
2022-12-31
|
0.00
|
-3.09
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-4.31
|
|
2023-12-31
|
-12.93
|
|
2022-12-31
|
-13.03
|
|
2021-12-31
|
-6.23
|